Skip to main content
SpringerLink
Log in

GM-CSF potentiated peripheral blood progenitor cell (PBPC) collection with or without bone marrow as hematologic support of high-dose chemotherapy: Two protocols

  • Minisymposium
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

High-dose chemotherapy with autologous bone marrow support (ABMS) achieves prolonged relapse-free survival in relapsed lymphomas and leukemias and has provided durable complete responses in certain solid tumors. The principal morbidity and mortality result from the infectious and bleeding complications during the 3–4 week aplasia until the bone marrow autograft can recover. Hematopoietic growth factors, alone or used after chemotherapy, increase the number of circulating progenitor cells in the peripheral blood compartment. In one trial, 12 patients with solid tumors were treated with high-dose chemotherapy and supported with both bone marrow and peripheral blood progenitor cells (PBPC) collected after GM-CSF administration. Reconstitution of bone marrow function occurred quickly (ANC >500/µl by day 17; platelet-transfusion independence by day 16), resulting in short hospital stays (median, 28 days). In a second study, 12 patients with metastatic breast cancer responding to induction chemotherapy (doxorubicin, 5-fluorouracil, and methotrexate) were given GM-CSF during induction to collect PBPCs during leukocyte recovery. These PBPCs were used as the sole hematopoietic support during high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin. Granulocyte and platelet reconstitution were extremely rapid (median, 14 and 12 days, respectively). When compared with 29 patients undergoing the same intensification therapy using ABMT as sole support, time to hematopoietic recovery, transfusion requirements, and duration of hospital stay were all significantly improved for the patients receiving PBPC. PBPC with or without marrow may enhance the safety, tolerance, and cost of high-dose therapy. Moreover, PBPC may render multiple course combination, high-dose therapy feasible.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Thomas ED: The role of marrow transplantation in the eradication of malignant disease. Cancer 49: 1963–1969, 1982

    PubMed  Google Scholar 

  2. Appelbaum FR, Herzig GP, Ziegler JL, Graw RG, Levine AS, Deisseroth AB: Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood 52: 85–95, 1978

    PubMed  Google Scholar 

  3. Takvorian T, Canellos GP, Ritz J, Freedman AS, Anderson KC, Manch P, Tarbell N, Coral F, Daley H, Yeap B, Schlossman SF, Nadler LM: Prolonged disease free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. N Engl J Med 316: 1499–1505, 1987

    PubMed  Google Scholar 

  4. Armitage JO, Jagannath S, Spitzer G, Bierman P, Kessinger A, Kumar P, Cabanillas F, Zander A, Vellekoop L, Dicke KA: High dose therapy and autologous marrow transplantation as salvage treatment for patients with diffuse large cell lymphoma. Eur J Cancer Clin Oncol 22: 871–877, 1986

    PubMed  Google Scholar 

  5. Appelbaum FR, Thomas ED: Review of the use of marrow transplantation in the treatment of non-Hodgkin's lymphoma. J Clin Oncol 1: 440–477, 1983

    PubMed  Google Scholar 

  6. McKredie KB, Hersh EM, Freireich EJ: Cells capable of colony formation in the peripheral blood of man. Science 171: 293–94, 1971

    PubMed  Google Scholar 

  7. Debelak-Fehir KM, Catchatourian R, Epstein RB: Hematopoietic colony forming units in fresh and cryopreserved peripheral blood cells of canines and man. Exp Hematol 3: 109–115, 1975

    PubMed  Google Scholar 

  8. Weiner R, Richman C, Yankee R: Semicontinuous flow centrifugation for the pheresis of immunocompetent cells and stem cells. Blood 49: 391–397, 1977

    PubMed  Google Scholar 

  9. Richman CM, Weiner RS, Yankee RA: Increase in circulating stem cells following chemotherapy in man. Blood 47: 1031–1039, 1976

    PubMed  Google Scholar 

  10. Lohrmann HP, Schreml W, Lang M, Betzler M, Fliedner TM, Heimpel H: Changes of granulopoiesis during and after adjuvant chemotherapy of breast cancer. Br J Haematol 40: 369–381, 1978

    PubMed  Google Scholar 

  11. Abrams RA, Johnston-Early A, Kramer C, Minna JD, Cohen MH, Deisseroth AB: Amplification of circulating granulocyte-monocyte stem cell numbers following chemotherapy in patients with extensive small cell carcinoma of the lung. Cancer Res 41: 35–41, 1981

    PubMed  Google Scholar 

  12. Stiff PJ, Murgo AJ, Wittes RE, DeRisi MF, Clarkson BD: Quantification of the peripheral blood colony forming unit-culture rise following chemotherapy: Could leukacytaphereses replace bone marrow for autologous transplantation? Transfusion 23: 500–503, 1983

    PubMed  Google Scholar 

  13. Ruse-Riol F, Legros M, Bernard D, Chassagne J, Clavel H, Ferriere JP, Chollet P, Plagne R: Variations in committed stem cells (CFU-GM and CFU-TL) in the peripheral blood of cancer patients treated by sequential combination chemotherapy for breast cancer. Cancer Res 44: 2219–2224, 1984

    PubMed  Google Scholar 

  14. To LB, Haylock DN, Kimber RJ, Juttner CA: High levels of circulating hematopoietic stem cells in very early remission from acute non-lymphocytic leukaemia and their collection and cryopreservation. Br J Haematol 58: 399–410, 1984

    PubMed  Google Scholar 

  15. Long G, Chao N, Negrin R, Horning S, O'Connor P, Stallbaum B, Blume K: Efficacy of peripheral blood-derived stem cell (PBSC) rescue compared with bone marrow plus PBSC rescue after high dose therapy. Blood 76(Suppl 1): 550a, 1990 (Abstract)

  16. Schwartzberg L, West W, Birch R, Tauer K, Lee P, Hazelton B: High dose cyclophosphamide (HD-CTX) or etoposide (HDVP-16) as mobilization chemotherapy for peripheral blood stem cell (PBSC) harvest. Blood 76(Suppl 1): 564a, 1990 (Abstract)

  17. Korbling M, Holle R, Haas R, Knauf W, Dörken B, Ho AD, Kuse R, Pralle H, Fliedner TM, Hunstein W: Autologous blood stem-cell transplantation in patients with advanced Hodgkin's Disease and prior radiation to the pelvic site. J Clin Oncol 8: 978–985, 1990

    PubMed  Google Scholar 

  18. Socinski MA, Cannistra SA, Elias A, Antman KH, Schnipper L, Griffin JD: Granulocyte-macrophage colony stimulating factor expands the circulating hematopoietic progenitor cell compartment in humans. Lancet 1: 1194–98, 1988

    PubMed  Google Scholar 

  19. Gianni AM, Bregni M, Siena S, Orazi A, Stern AC, Gandola L, Bonadonna G: Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. J Clin Oncol 8: 768–778, 1990

    PubMed  Google Scholar 

  20. Siena S, Bregni M, Brando B, Ravagnani F, Bonadonna G, Gianni AM: Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 74: 1905–1914, 1989

    PubMed  Google Scholar 

  21. Peters WP, Kurtzberg J, Kirkpatrick G, Atwater S, Gilbert C, Borowitz M, Shpall E, Jones R, Ross M, Affronte M, Coniglio D, Mathias B, Oette D: GMCSF primed peripheral blood progenitor cells (PBPC) coupled with autologous bone marrow transplantation will eliminate absolute leukopenia following high dose chemotherapy. Blood 76(Suppl 1): 50a, 1990 (Abstract)

  22. Sheridan WP, Juttner C, Szer J, Begley G, DeLuca E, Rowlings PA, McGrath K, Vincent M, Souza L, Morstyn G, Fox RM: Granulocyte colony-stimulating factor (G-CSF) in peripheral blood stem cell (PBSC) and bone marrow (BM) transplantation. Blood 76(Suppl 1): 565a, 1990 (Abstract)

  23. Shea TC, Mason JR, Storniolo AM, Newton B, Breslin M, Mullen M, Ward D, Taetle R: Beneficial effect from sequential harvesting and reinfusing of peripheral blood stem cells (PBSC) in conjunction with rHu GM-CSF (Schering-Sandoz) and high-dose carboplatin. Blood 76(Suppl 1): 165a, 1990 (Abstract)

  24. Alter R, Welniak LA, Jackson JD,et al: In-vitro clonogenic monitoring of peripheral blood stem cell collections following interleukin-3 administration. Blood 76(Suppl 1): 129a, 1990 (Abstract)

  25. Geissler K, Valent P, Mayer P, Liehl E, Hinterberger W, Lechner K, Bettelheim P: RhIL-3 expands the pool of circulating hemopoietic stem cells in primates — synergism with Rh GM-CSF. Blood 76(Suppl 1): 151a, 1990 (Abstract)

Download references

Author information

Authors and Affiliations

  1. Dana Farber Cancer Institute, Harvard Medical School, Harvard University, and Beth Israel Hospital, 44 Binney Street, 02115, Boston, MA, USA

    Anthony D. Elias, Rosemary Mazanet, Cathy Wheeler, Ken Anderson, Lois Ayash, Gary Schwartz, Isidore Tepler, Stephen Pap, Jorge Pelaez, Myla Hunt, Lowell Schnipper, James Griffin, Emil Frei & Karen Antman

Authors
  1. Anthony D. Elias
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rosemary Mazanet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cathy Wheeler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ken Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lois Ayash
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gary Schwartz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Isidore Tepler
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Stephen Pap
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jorge Pelaez
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Myla Hunt
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Lowell Schnipper
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. James Griffin
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Emil Frei
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Karen Antman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elias, A.D., Mazanet, R., Wheeler, C. et al. GM-CSF potentiated peripheral blood progenitor cell (PBPC) collection with or without bone marrow as hematologic support of high-dose chemotherapy: Two protocols. Breast Cancer Res Tr 20 (Suppl 1), S25–S29 (1991). https://doi.org/10.1007/BF01908241

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01908241

Key words

Search

Navigation